Bree Foster, PhD
Bree Foster is a science writer at Drug Discovery News with over 2 years of experience at Technology Networks, Drug Discovery News, and other scientific marketing agencies. She holds a PhD in comparative and functional genomics from the University of Liverpool and enjoys crafting compelling stories for science.
Articles by Bree Foster, PhD
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
| 3 min read
These latest deals give Lilly a complementary portfolio of life-changing therapies and scalable gene therapy platforms.
| 5 min read
Quantum-informed AI could open up unexplored chemical space, speeding the design of safer, more effective drugs.
| 4 min read
Early clinical trials show that a KRAS G12D inhibitor can shrink tumors in patients with advanced pancreatic and other solid cancers.
| 5 min read
A new study finds that non-core and non-essential procedures may add significant burden to participants and research sites.
| 6 min read
Harnessing human-first models to accelerate drug discovery, improve safety, and capture the diversity of human biology.
| 4 min read
Ignota Labs is using artificial intelligence to revive shelved drug candidates, reduce clinical risk, and cut carbon emissions.
| 3 min read
The new therapy combines a chemically enhanced drug with tumor-targeted delivery to overcome resistance and reduce side effects.
| 3 min read
The therapy exploits the properties of a neutrophil-derived enzyme to selectively kill tumor cells while preserving healthy immune cells.
| 4 min read
Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.
| 6 min read
With the first wave of FDA-approved siRNA drugs under their belt, companies are racing to expand into new tissues and indications.
| 3 min read
Researchers are using caraway seeds to create synthetic cannabidiol compounds for treating seizures.
